We turn biotech's promise into care that reaches people

bioERGOtech is a foundation, and an ecosystem of researchers, founders, clinicians and partners, building Engineered Living Systems through synthetic biology and AI-driven automation that move from the lab to real patient impact.

3

Innovation Hubs

Taranto · Zurich · Riyadh

4

Portfolio Companies

From diagnostics to robotics

4

Scientific Pillars

Integrated research domains

6+

Countries

Italy · Switzerland · Germany · US · China · Saudi Arabia

Why We Exist

The healthcare industry faces a critical gap: while groundbreaking research happens in laboratories worldwide, too many life-saving innovations never reach the patients who need them. Promising technologies remain trapped in academic settings instead of transforming lives.

bioERGOtech was founded to close that gap. We advance Engineered Living Systems, turning cells into predictable, manufacturable, and controllable living medicines, through four integrated scientific pillars: digital twin therapeutics, synthetic biology, automated biomanufacturing, and multi-omics analytics.

We believe breakthrough science must become breakthrough medicine.

Researchers at work in a bioERGOtech synthetic biology lab

How We Work

We are a not-for-profit foundation with commercial ambition, built to serve patients, powered by innovation.

bioERGOtech operates through a dual model designed to bridge the lab-to-market gap:

  • AI Development & Spin-off: We partner with healthcare organizations to develop and spin-off AI algorithms that address specific medical needs.
  • Technology Acceleration: We accelerate existing patents and lab technologies to market through strategic partnerships.
Scientists and founders collaborating in the bioERGOtech ecosystem
Guido Putignano

We founded bioERGOtech because we saw too many life-saving innovations trapped between the lab bench and the patient bedside. Our mission is not to make research incrementally better. It is to make it fundamentally smarter, so that breakthroughs reach the people who need them most.

Guido Putignano

President & Founder, bioERGOtech Foundation

Our 6 Core Values

Servant Ambition

We pursue breakthroughs to serve humanity, matching our ambition with humility.

Intelligent Agency

We act with autonomy and responsibility to solve problems and seize opportunities.

Sustainable Impact

We build solutions that are both scientifically sound and economically viable.

Generous Excellence

We share knowledge freely while demanding the highest standards from ourselves.

Proximity to Genius

We bring together exceptional people to spark breakthrough discoveries.

Adaptive Resilience

We reframe every setback as a redirection toward a better solution.

Who We Are

Leadership

Guido Putignano, President

Guido Putignano

President

Specialized in computational biology, with experience in engineering and AI-driven biomedical solutions.

Mimma Leone, Board Member

Mimma Leone

Board Member

Legal expert and entrepreneur focused on advancing educational and university projects.

Carmine Pisano, Board Member

Carmine Pisano

Board Member

Expert in public administration and urban development, specializing in digital transformation.

Giacomo Ferrazzini, Scientific Projects Lead

Giacomo Ferrazzini

Scientific Projects Lead

Medical student at ETH Zurich and USI, combining advanced medical training with leadership in health science initiatives.

Alessia Soru, Scientific Projects Lead

Alessia Soru

Scientific Projects Lead

PhD student in Oncology, Hematology and Pathology at the University of Bologna, and Board Member of Women&Tech® ETS.

Saria Miccoli, Communication Lead

Saria Miccoli

Communication Lead

Experienced designer who shapes the Foundation's visual identity and communications.

Olufemi Olusola, Scientific Projects Lead

Olufemi Olusola

Scientific Projects Lead

Biostatistician working at the intersection of agentic AI, clinical data, and digital twin therapeutics.

Luigi Fantini, Strategy Lead

Luigi Fantini

Strategy Lead

Sales and outreach specialist who has built a career on connecting with people and reaching new markets.

Oscar Carrisi, Strategy Lead

Oscar Carrisi

Strategy Lead

CEO at Priver and a strategy expert focused on growth and market positioning.

Mario Tagarelli, Auditor

Mario Tagarelli

Auditor

Career auditor responsible for the Foundation's financial oversight and compliance.

Advisory Board

Daniela Marotto, Doctor

Daniela Marotto

Doctor

Rheumatologist and leader in Italian health science, recognized for her commitment to multidisciplinary care.

Pasquale Persico, Market Access

Pasquale Persico

Market Access

Market access and pharma strategy expertise at Gilead Sciences, covering regulatory and reimbursement pathways.

Roberto De Ponti, Investor

Roberto De Ponti

Investor

Managing Director and General Partner at 3B Future Health Fund, a healthcare and biotech venture fund investing in pharmaceuticals and therapeutics at seed and Series A stages.

Domenico Amalfitano, Policy

Domenico Amalfitano

Policy

Politician working at the intersection of complex systems and society.

Our Partners

Strategic research partnerships, healthcare collaborators, portfolio companies, and industry partners.

Our Supporters

Advisory board members, industry mentors, institutional endorsers, and key community voices.

Our Donors

Founding donors, institutional funders, and individual contributors who fuel our mission.

Be Part of What We're Building

Whether you're a researcher, innovator, healthcare professional, or supporter, there's a place for you in the bioERGOtech ecosystem.

Join UsPartner With UsBuild With Us